A dominant gain-of-function mutation in universal tyrosine kinase <i>SRC</i> causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologiesErnest Turro, Willem H. Ouwehand, Rémi Favier et al.|Science Translational Medicine|2016Cited by 144